The Scientist

» immunotherapy

Most Recent

image: Speaking of Science

Speaking of Science

By | April 1, 2016

April 2016's selection of notable quotes

0 Comments

image: Immune Influence

Immune Influence

By | April 1, 2016

In recent years, research has demonstrated that microbes living in and on the mammalian body can affect cancer risk, as well as responses to cancer treatment.

0 Comments

image: Microbes Meet Cancer

Microbes Meet Cancer

By | April 1, 2016

Understanding cancer’s relationship with the human microbiome could transform immune-modulating therapies.

4 Comments

image: Cancer Be Damned

Cancer Be Damned

By | April 1, 2016

Teenager Lauren Bendesky turned her cancer diagnosis on its head, using herself as a research subject to test potential therapies.

2 Comments

image: TS Picks: March 16, 2016

TS Picks: March 16, 2016

By | March 16, 2016

Corrections give belated credit for immunotherapy; mosquitoes have been bugging us long before Zika; the bright side of irreproducibility 

0 Comments

image: MYC Helps Cancer Hide

MYC Helps Cancer Hide

By | March 10, 2016

The transcriptional regulator dampens the immune system’s ability to elicit an antitumor response, a study shows.

1 Comment

image: Single Antibody Protects Macaques from Ebola

Single Antibody Protects Macaques from Ebola

By | February 25, 2016

The “just right” binding properties of a monoclonal antibody from an Ebolavirus survivor help it neutralize the virus.

0 Comments

image: Week in Review: November 2–6

Week in Review: November 2–6

By | November 6, 2015

How Ebola hides from immune cells; gut microbes’ role in immunotherapy response; new mechanisms of hearing loss; butterflies use milkweed toxins to ward off predators

0 Comments

image: Two-Faced Proteins May Tackle HIV Reservoirs

Two-Faced Proteins May Tackle HIV Reservoirs

By | October 21, 2015

Researchers design antibody-like proteins to awaken and destroy HIV holdouts.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech